Navigation Links
Data on VIVUS' QNEXA to be Presented in Six Posters at The Obesity Society's Annual Meeting
Date:10/7/2010

e not limited to, substantial competition; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; reliance on sole source suppliers; limited sales and marketing efforts and dependence upon third parties; risks related to the development of innovative products; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical studies discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ended December 31, 2009 and periodic reports filed with the Securities and Exchange Commission. CONTACT:   VIVUS, Inc.Investor Relations:Media Relations:Timothy E. MorrisThe Trout GroupGolinHarrisChief Financial Officer

Brian Korb

Susan Brophy650-934-5200

646-378-2923

sbrophy@golinharris.comBKorb@troutgroup.com

312-729-4359
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. VIVUS Reports First Quarter 2009 Financial Results and Highlights
2. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
3. VIVUS to Present at the Needham and Company Life Sciences Conference
4. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. VIVUS to Present at Four Upcoming Healthcare Conferences
6. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
7. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
8. VIVUS to Present at Two Upcoming Investor Conferences
9. VIVUS to Present at Four Upcoming Investor Conferences
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. ApoA-I Data Presented at European Society of Cardiology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... of Guggenheim Partners, today announced the hiring of veteran ... and senior equity analyst. Mr. Butler will focus on ... brings our team a wealth of experience and a ... Dante Ferrarie , Senior Managing Director and Head of ...
(Date:8/27/2014)... Aug. 27, 2014 Research and Markets ... Enzyme for Pulp & Paper Industry Report 2014" ... Enzyme for Pulp & Paper Industry Report 2014 is ... of the global enzyme for pulp & paper industry. ... the industry including definitions, classifications, applications and industry chain ...
(Date:8/27/2014)... Tris Pharma, a specialty pharmaceutical company focused ... it has been selected as an award winner in ... Awards for Excellence competition in the Business Expansion ... judges from SCORE (Counselors to America,s Small Business) and ... at a gala event to be held on October ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
Breaking Biology Technology:Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Global Enzyme for Pulp & Paper Industry Report 2014 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4
... 22 Kiadis Pharma announced today,that its lead ... by the European Medicines Agency (EMEA) for the ... an allogeneic bone marrow,transplantation., "Following the orphan ... lead,product ATIR(TM), this is another important milestone in ...
... cotton, altered to express the insecticide, Bt, not only reduces ... other nearby crops that have not been modified with Bt. ... and maximizing crop yields in the future. , The ... on Friday, 19 September. Science is the journal ...
... nanostructures which respond to stimuli, such as pH, heat ... and more efficient chemical reactors. , Being developed by ... reactions, momentum, and heat and mass transfer inside chemical ... reactor technology for the chemical, pharmaceutical and agrochemical industries. ...
Cached Biology Technology:EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation 2GM crops protect neighbors from pests 2
(Date:8/26/2014)... plasmonics and optical microresonators, researchers at the University ... optical amplifier (or laser) design, paving the way ... optical systems at the microscopic scale that amplify ... Gary Eden, a professor of electrical and computer ... are well-suited for routing optical power on a ...
(Date:8/26/2014)... and the PETA International Science Consortium, LTD (PISC) scientists ... World Congress on Alternatives and Animal Use in the ... use of animals in research, testing and medical training, ... oversight systems. , At the conference, which is being ... PISC will present seven oral and poster presentations, including: ...
(Date:8/25/2014)... reveals that the US has experienced widespread adoption ... cancer in recent years. The BJU International ... are more expensive than traditional surgeries, their costs ... began using robotic technologies in operations to remove ... of such robotic-assisted radical prostatectomy (RARP) procedures for ...
Breaking Biology News(10 mins):Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2US has seen widespread adoption of robot-assisted cancer surgery to remove the prostate 2
... Aluminum toxicity, a global agricultural problem, halts root ... than half of the world,s arable land. For ... of aluminum damage the growing root. The popular understanding ... root system, blocking cell division, damaging DNA, and ultimately ...
... models and live cell experiments, biomedical engineers at the Johns ... human protein fragments that can slow or stop the growth ... Reporting online last week in the Proceedings of the ... could lead to developing treatments to fight diseases that depend ...
... WEST LAFAYETTE, Ind. - While cellulosic biofuels derived from ... potential to be more efficient and environmentally friendly than ... policies are needed to reap these benefits, says an ... Friday (Oct. 3) in the journal Science, ...
Cached Biology News:UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 2UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 3Discovery of natural compounds that could slow blood vessel growth 2More research needed to make good on biofuel promise, experts say 2
Synonym: modified Grace's Insect medium...
Eagle's Ham's amino acids; EHAA...
Schneider's Drosophila - Insect medium...
... protein separation by two-dimensional electrophoresis (2D-PAGE), ... package from Bio-Rad and protein identification ... to meet customers requirements regarding experimental ... format of the results permanent contact ...
Biology Products: